Anaesthesia
Conditions
Interventions
Dexmedetomidine
magnesium sulphate
Sponsors
Primary Sponsor
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1-Patients of American Society of Anaesthesiologists (ASA) physical status I and II 2-Patients of both sex having age group between 18-60 years old electively scheduled for rhinoplasty under general anesthesia.
Exclusion criteria
Exclusion criteria: 1. Refusal of the procedure or participation in the study. 2. Intraoperative hemodynamic instability. 3. Patients who require awake intubation. 4. Patients having hypertension or ischemic heart disease. 5. Patients with heart block, hepatic, renal and cerebral impairment, or with known coagulopathies. 6. Patients having history of allergy to the study drug used. 7. Patients on ACE inhibitors, a-2 adrenergic receptor blockers, Calcium channel blockers or beta blockers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Heart rate. 2.Mean arterial blood pressure. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-Surgical field will be assessed by the surgeon in terms of bleeding and visibility. 2-During postoperative period, the 2 groups will also be compared accordingly for the occurrence of the side effects as bradycardia, shivering, nausea, and vomiting to assess each drug effects on these side effect | — |
Countries
Egypt
Contacts
Public Contactsarah abdelhalem
assistant lecturer of Anesthesia and intensive care at faculty of Medicine Ain Shams University
Outcome results
None listed